PMID- 2557390 OWN - NLM STAT- MEDLINE DCOM- 19900130 LR - 20131121 IS - 0732-6580 (Print) IS - 0732-6580 (Linking) VI - 8 IP - 6 DP - 1989 Dec TI - Comparative effects of F1 and P1 fractions obtained from a Klebsiella pneumoniae glycoproteic extract (RU 41740) on polymorphonuclear leukocytes. PG - 656-64 AB - RU 41740 is a glycoprotein extract from Klebsiella pneumoniae described as a macromolecular aggregation of a lipopolysaccharide (LPS)-associated protein (F1 fraction) and a glycoproteic complex (P1 fraction). The human polymorphonuclear (PMN) response was studied after incubation of the cells in the presence of RU 41740, F1 and P1 fractions, or F1-P1 complex. Oxidative metabolism was assessed by chemiluminescence, O2 consumption, O2- generation, and degranulation by beta-glucuronidase release. Results were compared to data obtained with a homologous LPS. RU 41740, F1 fraction, and F1-P1 complex increased the respiratory burst of PMNs stimulated by opsonized zymosan (OZ). N-formylmethionylleucylphenylalanine (fMLP), phorbol myristate acetate, or the calcium ionophore A23187. The beta-glucuronidase release was stimulated by the same compounds when OZ or fMLP were used as stimuli. These effects were dose-dependent. In contrast, P1 fraction was inactive. Addition of polymyxin B resulted in a profound inhibition of both the F1 fraction and LPS activities but only in a partial inhibition of RU 41740 effects. These results strengthen the hypothesis that different biochemical pathways are involved in the enhancement of stimulated neutrophil functions by RU 41740. FAU - el Abbouyi, A AU - el Abbouyi A AD - Laboratoire de Pharmacologie, Hopital Cochin, Paris, France. FAU - Paul, J L AU - Paul JL FAU - Roch-Arveiller, M AU - Roch-Arveiller M FAU - Sarfati, G AU - Sarfati G FAU - Giroud, J P AU - Giroud JP FAU - Raichvarg, D AU - Raichvarg D LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - J Biol Response Mod JT - Journal of biological response modifiers JID - 8219656 RN - 0 (Adjuvants, Immunologic) RN - 0 (Bacterial Proteins) RN - 11062-77-4 (Superoxides) RN - 37H9VM9WZL (Calcimycin) RN - 59880-97-6 (N-Formylmethionine Leucyl-Phenylalanine) RN - 68583-24-4 (glycoprotein, Klebsiella pneumoniae) RN - 9010-72-4 (Zymosan) RN - EC 3.2.1.31 (Glucuronidase) RN - NI40JAQ945 (Tetradecanoylphorbol Acetate) SB - IM MH - Adjuvants, Immunologic/*pharmacology MH - Bacterial Proteins/*pharmacology MH - Calcimycin/pharmacology MH - Chemical Fractionation MH - Glucuronidase/blood MH - Humans MH - Klebsiella pneumoniae/*analysis MH - Luminescent Measurements MH - N-Formylmethionine Leucyl-Phenylalanine/pharmacology MH - Neutrophils/*drug effects MH - Oxygen Consumption/drug effects MH - Superoxides/blood MH - Tetradecanoylphorbol Acetate/pharmacology MH - Zymosan/pharmacology EDAT- 1989/12/01 00:00 MHDA- 1989/12/01 00:01 CRDT- 1989/12/01 00:00 PHST- 1989/12/01 00:00 [pubmed] PHST- 1989/12/01 00:01 [medline] PHST- 1989/12/01 00:00 [entrez] PST - ppublish SO - J Biol Response Mod. 1989 Dec;8(6):656-64.